Glutamatergic agents for schizophrenia: current evidence and perspectives
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Glutamatergic agents for schizophrenia: current evidence and perspectives
Authors
Keywords
-
Journal
Expert Review of Clinical Pharmacology
Volume 8, Issue 3, Pages 335-352
Publisher
Informa UK Limited
Online
2015-04-28
DOI
10.1586/17512433.2015.1040393
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Electroconvulsive Therapy Augmentation in Clozapine-Resistant Schizophrenia: A Prospective, Randomized Study
- (2015) Georgios Petrides et al. AMERICAN JOURNAL OF PSYCHIATRY
- Improvement of dizocilpine-induced social recognition deficits in mice by brexpiprazole, a novel serotonin–dopamine activity modulator
- (2015) Noriko Yoshimi et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Towards stage specific treatments: Effects of duration of illness on therapeutic response to adjunctive treatment with N-acetyl cysteine in schizophrenia
- (2015) Marta Rapado-Castro et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Cognitive–behavioural therapy for the symptoms of schizophrenia: systematic review and meta-analysis with examination of potential bias
- (2014) S. Jauhar et al. BRITISH JOURNAL OF PSYCHIATRY
- Antipsychotic treatment modulates glutamate transport and NMDA receptor expression
- (2014) Mathias Zink et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- A phase II/III trial of bitopertin monotherapy compared with placebo in patients with an acute exacerbation of schizophrenia – Results from the CandleLyte study
- (2014) D. Bugarski-Kirola et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Emerging drugs for schizophrenia: an update
- (2014) Luisa-Sophie Köster et al. EXPERT OPINION ON EMERGING DRUGS
- Investigational drugs for anxiety in patients with schizophrenia
- (2014) Ricardo P Garay et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Efficacy and tolerability of minocycline augmentation therapy in schizophrenia: a systematic review and meta-analysis of randomized controlled trials
- (2014) Kazuto Oya et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Effectiveness of Paliperidone Palmitate vs Haloperidol Decanoate for Maintenance Treatment of Schizophrenia
- (2014) Joseph P. McEvoy et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Mechanism of Action of Antipsychotic Medications
- (2014) Christoph U. Correll JOURNAL OF CLINICAL PSYCHIATRY
- The Endocannabinoid System and Schizophrenia: Links to the Underlying Pathophysiology and to Novel Treatment Approaches
- (2014) Swapnil Gupta et al. JOURNAL OF CLINICAL PSYCHIATRY
- Effects of brexpiprazole, a novel serotonin-dopamine activity modulator, on phencyclidine-induced cognitive deficits in mice: A role for serotonin 5-HT1A receptors
- (2014) Noriko Yoshimi et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Clozapine Augmented with Glutamate Modulators in Refractory Schizophrenia: A Review and Metaanalysis
- (2014) S. Veerman et al. PHARMACOPSYCHIATRY
- Comparative Effectiveness of Risperidone Long-Acting Injectable vs First-Generation Antipsychotic Long-Acting Injectables in Schizophrenia: Results From a Nationwide, Retrospective Inception Cohort Study
- (2014) J. Nielsen et al. SCHIZOPHRENIA BULLETIN
- Glutamate receptor 1 phosphorylation at serine 845 contributes to the therapeutic effect of olanzapine on schizophrenia-like cognitive impairments
- (2014) Chen Zhang et al. SCHIZOPHRENIA RESEARCH
- Effect of Bitopertin, a Glycine Reuptake Inhibitor, on Negative Symptoms of Schizophrenia
- (2014) Daniel Umbricht et al. JAMA Psychiatry
- Atypical antipsychotic olanzapine reversed deficit on prepulse inhibition of the acoustic startle reflex produced by microinjection of dizocilpine (MK-801) into the inferior colliculus in rats
- (2013) Julia Zangrando et al. BEHAVIOURAL BRAIN RESEARCH
- The reversal of cognitive, but not negative or positive symptoms of schizophrenia, by the mGlu2/3 receptor agonist, LY379268, is 5-HT1A dependent
- (2013) Joanna M. Wierońska et al. BEHAVIOURAL BRAIN RESEARCH
- Antipsychotic Treatment Resistance in Schizophrenia Associated with Elevated Glutamate Levels but Normal Dopamine Function
- (2013) Arsime Demjaha et al. BIOLOGICAL PSYCHIATRY
- When the drugs don't work: the potential of glutamatergic antipsychotics in schizophrenia
- (2013) Evangelos Papanastasiou et al. BRITISH JOURNAL OF PSYCHIATRY
- Attitudes towards psychiatric treatment and people with mental illness: changes over two decades
- (2013) Matthias C. Angermeyer et al. BRITISH JOURNAL OF PSYCHIATRY
- Risks and Benefits of Bupropion Treatment in Schizophrenia
- (2013) Susanne Englisch et al. CLINICAL NEUROPHARMACOLOGY
- Glutamate modulators as potential therapeutic drugs in schizophrenia and affective disorders
- (2013) Kenji Hashimoto et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- AMPA receptor positive allosteric modulators: a patent review
- (2013) Bernard Pirotte et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Assessing the comparative effectiveness of long-acting injectable vs. oral antipsychotic medications in the prevention of relapse provides a case study in comparative effectiveness research in psychiatry
- (2013) John M. Kane et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Long-Acting Injectable Versus Oral Antipsychotics in Schizophrenia
- (2013) Taishiro Kishimoto et al. JOURNAL OF CLINICAL PSYCHIATRY
- Antipsychotic Polypharmacy in a Treatment-Refractory Schizophrenia Population Receiving Adjunctive Treatment With Electroconvulsive Therapy
- (2013) Diana Kristensen et al. JOURNAL OF ECT
- Comparative effect of lurasidone and blonanserin on cortical glutamate, dopamine, and acetylcholine efflux: role of relative serotonin (5-HT)2Aand DA D2antagonism and 5-HT1Apartial agonism
- (2013) Mei Huang et al. JOURNAL OF NEUROCHEMISTRY
- Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
- (2013) Stefan Leucht et al. LANCET
- N-acetyl cysteine reverses social isolation rearing induced changes in cortico-striatal monoamines in rats
- (2013) Marisa Möller et al. METABOLIC BRAIN DISEASE
- Effects of pregabalin on behavioral alterations induced by ketamine in rats
- (2013) Emerson Arcoverde Nunes et al. REVISTA BRASILEIRA DE PSIQUIATRIA
- Adjunctive Use of Nonsteroidal Anti-inflammatory Drugs for Schizophrenia: A Meta-analytic Investigation of Randomized Controlled Trials
- (2013) Masahiro Nitta et al. SCHIZOPHRENIA BULLETIN
- Pomaglumetad methionil: No significant difference as an adjunctive treatment for patients with prominent negative symptoms of schizophrenia compared to placebo
- (2013) Virginia L. Stauffer et al. SCHIZOPHRENIA RESEARCH
- Personal stigma in schizophrenia spectrum disorders: a systematic review of prevalence rates, correlates, impact and interventions
- (2013) Gabriel Gerlinger et al. World Psychiatry
- Non-adherence to medication in patients with psychotic disorders: epidemiology, contributing factors and management strategies
- (2013) John M. Kane et al. World Psychiatry
- Glutamate Levels in the Associative Striatum Before and After 4 Weeks of Antipsychotic Treatment in First-Episode Psychosis
- (2013) Camilo de la Fuente-Sandoval et al. JAMA Psychiatry
- Comorbid obsessive-compulsive symptoms in schizophrenia: contributions of pharmacological and genetic factors
- (2013) Frederike Schirmbeck et al. Frontiers in Pharmacology
- Rediscovering catatonia: the biography of a treatable syndrome
- (2012) Max Fink ACTA PSYCHIATRICA SCANDINAVICA
- The Nature of Dopamine Dysfunction in Schizophrenia and What This Means for Treatment
- (2012) Oliver D. Howes et al. ARCHIVES OF GENERAL PSYCHIATRY
- Social isolation rearing induces mitochondrial, immunological, neurochemical and behavioural deficits in rats, and is reversed by clozapine or N-acetyl cysteine
- (2012) Marisa Möller et al. BRAIN BEHAVIOR AND IMMUNITY
- Clozapine, but not haloperidol, enhances glial d-serine and L-glutamate release in rat frontal cortex and primary cultured astrocytes
- (2012) Shunske Tanahashi et al. BRITISH JOURNAL OF PHARMACOLOGY
- Altered Cortical GABA Neurotransmission in Schizophrenia: Insights into Novel Therapeutic Strategies
- (2012) Ana D. Stan et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Aripiprazole differentially regulates the expression of Gad67 and γ-aminobutyric acid transporters in rat brain
- (2012) Nina Peselmann et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Glycine treatment of the risk syndrome for psychosis: Report of two pilot studies
- (2012) Scott W. Woods et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- d-serine and schizophrenia: an update
- (2012) Emerson A Nunes et al. Expert Review of Neurotherapeutics
- Pregabalin-Associated Increase of Clozapine Serum Levels
- (2012) Susanne Englisch et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents
- (2012) S Miyamoto et al. MOLECULAR PSYCHIATRY
- The effect of pregabalin on sensorimotor gating in ‘low’ gating humans and mice
- (2012) Dean T. Acheson et al. NEUROPHARMACOLOGY
- Metabotropic glutamate receptor 5 in the pathology and treatment of schizophrenia
- (2012) Natalie Matosin et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Glutathione Precursor N-Acetyl-Cysteine Modulates EEG Synchronization in Schizophrenia Patients: A Double-Blind, Randomized, Placebo-Controlled Trial
- (2012) Cristian Carmeli et al. PLoS One
- Long-Acting Injectable vs Oral Antipsychotics for Relapse Prevention in Schizophrenia: A Meta-Analysis of Randomized Trials
- (2012) T. Kishimoto et al. SCHIZOPHRENIA BULLETIN
- A Systematic Review and Meta-Analysis of Recovery in Schizophrenia
- (2012) E. Jaaskelainen et al. SCHIZOPHRENIA BULLETIN
- World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 2: Update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects
- (2012) Alkomiet Hasan et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- The Psychosis High-Risk State
- (2012) Paolo Fusar-Poli et al. JAMA Psychiatry
- Optimizing clozapine treatment
- (2011) J. Nielsen et al. ACTA PSYCHIATRICA SCANDINAVICA
- Randomized Trial to Evaluate the Efficacy of Cognitive Therapy for Low-Functioning Patients With Schizophrenia
- (2011) Paul M. Grant ARCHIVES OF GENERAL PSYCHIATRY
- The role of serotonin receptors in the action of atypical antipsychotic drugs
- (2011) HY Meltzer et al. CURRENT OPINION IN PHARMACOLOGY
- A Multicenter, Inpatient, Phase 2, Double-Blind, Placebo-Controlled Dose-Ranging Study of LY2140023 Monohydrate in Patients With DSM-IV Schizophrenia
- (2011) Bruce J. Kinon et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Blockade of glycine transporter 1 by SSR-504734 promotes cognitive flexibility in glycine/NMDA receptor-dependent manner
- (2011) Agnieszka Nikiforuk et al. NEUROPHARMACOLOGY
- Glycine Transporter Inhibitor Attenuates the Psychotomimetic Effects of Ketamine in Healthy Males: Preliminary Evidence
- (2011) Deepak Cyril D'Souza et al. NEUROPSYCHOPHARMACOLOGY
- Lamotrigine blocks repeated high-dose methamphetamine-induced behavioral sensitization to dizocilpine (MK-801), but not methamphetamine in rats
- (2011) Yasuya Nakato et al. NEUROSCIENCE LETTERS
- Cognitive behavior therapy for schizophrenia: A meta-analytical review of randomized controlled trials
- (2011) Freddy Sarin et al. NORDIC JOURNAL OF PSYCHIATRY
- Glutamate signaling in the pathophysiology and therapy of schizophrenia
- (2011) Chieh-Hsin Lin et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Differential effects of AMPA receptor potentiators and glycine reuptake inhibitors on antipsychotic efficacy and prefrontal glutamatergic transmission
- (2011) Kent Jardemark et al. PSYCHOPHARMACOLOGY
- Effects of chronic oral treatment with aripiprazole on the expression of NMDA receptor subunits and binding sites in rat brain
- (2011) Nina Segnitz et al. PSYCHOPHARMACOLOGY
- Interaction of mGlu2/3 agonism with clozapine and lurasidone to restore novel object recognition in subchronic phencyclidine-treated rats
- (2011) Masakuni Horiguchi et al. PSYCHOPHARMACOLOGY
- Pharmacological Augmentation Strategies for Schizophrenia Patients With Insufficient Response to Clozapine: A Quantitative Literature Review
- (2011) Iris E. Sommer et al. SCHIZOPHRENIA BULLETIN
- Antipsychotic drugs prevent the motor hyperactivity induced by psychotomimetic MK-801 in zebrafish (Danio rerio)
- (2010) Kelly Juliana Seibt et al. BEHAVIOURAL BRAIN RESEARCH
- Early Life Programming and Neurodevelopmental Disorders
- (2010) Tracy L. Bale et al. BIOLOGICAL PSYCHIATRY
- Polypharmacy in schizophrenia
- (2010) Mathias Zink et al. CURRENT OPINION IN PSYCHIATRY
- Strategies to Enhance N-Methyl-D-Aspartate Receptor-Mediated Neurotransmission in Schizophrenia, a Critical Review and Meta-Analysis
- (2010) Guochuan Tsai et al. CURRENT PHARMACEUTICAL DESIGN
- Unraveling Monoamine Receptors Involved in the Action of Typical and Atypical Antipsychotics on Glutamatergic and Serotonergic Transmission in Prefrontal Cortex
- (2010) Xavier Lopez-Gil et al. CURRENT PHARMACEUTICAL DESIGN
- From receptor pharmacology to improved outcomes: individualising the selection, dosing, and switching of antipsychotics
- (2010) C.U. Correll EUROPEAN PSYCHIATRY
- Research in people with psychosis risk syndrome: a review of the current evidence and future directions
- (2010) Christoph U. Correll et al. JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY
- Clozapine: More Side Effects but Still the Best Antipsychotic
- (2010) Xin Kang et al. JOURNAL OF CLINICAL PSYCHIATRY
- Past and Present Progress in the Pharmacologic Treatment of Schizophrenia
- (2010) John M. Kane et al. JOURNAL OF CLINICAL PSYCHIATRY
- Topiramate Augmentation in Clozapine-Treated Patients With Schizophrenia
- (2010) Margaret K. Hahn et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Augmentation With Pregabalin in Schizophrenia
- (2010) Susanne Englisch et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- The effects of the glycine reuptake inhibitor R213129 on the central nervous system and on scopolamine-induced impairments in psychomotor and cognitive function in healthy subjects
- (2010) M Liem-Moolenaar et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Topiramate augmentation of clozapine in schizophrenia: a double-blind, placebo-controlled study
- (2010) MRA Muscatello et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Rethinking schizophrenia
- (2010) Thomas R. Insel NATURE
- Antipsychotic-like effects of the N-methyl-d-aspartate receptor modulator neboglamine: An immunohistochemical and behavioural study in the rat
- (2010) Riccardo Chiusaroli et al. PHARMACOLOGICAL RESEARCH
- Bupropion for Depression in Schizophrenia: A Case Report
- (2010) S. Englisch et al. PHARMACOPSYCHIATRY
- Sertindole restores attentional performance and suppresses glutamate release induced by the NMDA receptor antagonist CPP
- (2010) Mirjana Carli et al. PSYCHOPHARMACOLOGY
- Clozapine, GABAB, and the Treatment of Resistant Schizophrenia
- (2009) Z J Daskalakis et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Receptor mapping: architecture of the human cerebral cortex
- (2009) Karl Zilles et al. CURRENT OPINION IN NEUROLOGY
- D1-like receptor activation improves PCP-induced cognitive deficits in animal models: Implications for mechanisms of improved cognitive function in schizophrenia
- (2009) Samantha L. McLean et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Aripiprazole differentially affects mesolimbic and nigrostriatal dopaminergic transmission: implications for long-term drug efficacy and low extrapyramidal side-effects
- (2009) Mei Han et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Adding Lithium or Anticonvulsants to Antipsychotics for the Treatment of Schizophrenia: Useful Strategy or Exercise in Futility?
- (2009) Leslie Citrome JOURNAL OF CLINICAL PSYCHIATRY
- A Double-Blind, Randomized Study of Minocycline for the Treatment of Negative and Cognitive Symptoms in Early-Phase Schizophrenia
- (2009) Yechiel Levkovitz et al. JOURNAL OF CLINICAL PSYCHIATRY
- A Double-Blind Randomized Trial of Mood Stabilizer Augmentation Using Lamotrigine and Valproate for Patients With Schizophrenia Who Are Stabilized and Partially Responsive
- (2009) Ira D. Glick et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Schizophrenia
- (2009) Jim van Os et al. LANCET
- 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study)
- (2009) Jari Tiihonen et al. LANCET
- Mechanism of differential control of NMDA receptor activity by NR2 subunits
- (2009) Marc Gielen et al. NATURE
- Differential expression of glutamate transporter genes after chronic oral treatment with aripiprazole in rats
- (2009) Nina Segnitz et al. NEUROCHEMISTRY INTERNATIONAL
- Uncoupling Dendrite Growth and Patterning: Single-Cell Knockout Analysis of NMDA Receptor 2B
- (2009) J. Sebastian Espinosa et al. NEURON
- Mice with genetically altered glutamate receptors as models of schizophrenia: A comprehensive review
- (2009) Dragos Inta et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Pregabalin in the Treatment of Schizophrenic Anxiety
- (2009) C. Schönfeldt-Lecuona et al. PHARMACOPSYCHIATRY
- The neuropsychology of the schizo-obsessive subtype of schizophrenia: a new analysis
- (2009) D. D. Patel et al. PSYCHOLOGICAL MEDICINE
- The efficacy of lamotrigine in clozapine-resistant schizophrenia: A systematic review and meta-analysis
- (2009) Jari Tiihonen et al. SCHIZOPHRENIA RESEARCH
- Differential effects of topiramate on prefrontal glutamatergic transmission when combined with raclopride or clozapine
- (2009) Kent E. Jardemark et al. SYNAPSE
- Asenapine exerts distinctive regional effects on ionotropic glutamate receptor subtypes in rat brain
- (2009) Frank I. Tarazi et al. SYNAPSE
- Improvement of phencyclidine-induced social behaviour deficits in rats: Involvement of 5-HT1A receptors
- (2008) Shikha Snigdha et al. BEHAVIOURAL BRAIN RESEARCH
- N-Acetyl Cysteine as a Glutathione Precursor for Schizophrenia—A Double-Blind, Randomized, Placebo-Controlled Trial
- (2008) Michael Berk et al. BIOLOGICAL PSYCHIATRY
- Minocycline as Adjunctive Therapy for Schizophrenia
- (2008) Tsuyoshi Miyaoka et al. CLINICAL NEUROPHARMACOLOGY
- Clinical Potential of Minocycline for Schizophrenia
- (2008) Tsuyoshi Miyaoka CNS & Neurological Disorders-Drug Targets
- Effects of risperidone on glutamate receptor subtypes in developing rat brain
- (2008) Yong Kee Choi et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Topiramate add-on treatment in schizophrenia: a randomised, double-blind, placebo-controlled clinical trial
- (2008) H Afshar et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Anxiolytic profile of pregabalin on elicited hippocampal theta oscillation
- (2008) Chester J. Siok et al. NEUROPHARMACOLOGY
- Divalproex ER Combined with Olanzapine or Risperidone for Treatment of Acute Exacerbations of Schizophrenia
- (2008) Daniel E Casey et al. NEUROPSYCHOPHARMACOLOGY
- A Randomized, Placebo-Controlled Study of Memantine as Adjunctive Treatment in Patients with Schizophrenia
- (2008) Jeffrey A Lieberman et al. NEUROPSYCHOPHARMACOLOGY
- Allosteric modulation of NMDA receptor via elevation of brain glycine and d-serine: The therapeutic potentials for schizophrenia
- (2008) Charles R. Yang et al. PHARMACOLOGY & THERAPEUTICS
- Orbitofrontal cortex neurons as a common target for classic and glutamatergic antipsychotic drugs
- (2008) H. Homayoun et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Aripiprazole ameliorates phencyclidine-induced impairment of recognition memory through dopamine D1 and serotonin 5-HT1A receptors
- (2008) Taku Nagai et al. PSYCHOPHARMACOLOGY
- Expression of D-serine and glycine transporters in the prefrontal cortex and cerebellum in schizophrenia
- (2008) P BURNET et al. SCHIZOPHRENIA RESEARCH
- Aripiprazole, an atypical antipsychotic, prevents the motor hyperactivity induced by psychotomimetics and psychostimulants in mice
- (2007) Juliana V. Leite et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Addition of memantine to antipsychotic treatment in schizophrenia inpatients with residual symptoms: A preliminary study
- (2007) Amir Krivoy et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Effects of aripiprazole/OPC-14597 on motor activity, pharmacological models of psychosis, and brain activity in rats
- (2007) R.E. Nordquist et al. NEUROPHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started